Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesASTRO 2026ASTRO: Proton RT controls high-risk neuroblastomaFindings support PRT as a strategy to reduce long-term morbidity without compromising oncologic outcomes.ASTRO 2026ASTRO: How does tumor location affect survival in patients with esophageal cancer?CTCT-based AI model predicts pneumonitis in lung cancer patientsWomens ImagingWomen's Imaging MinnieCast, Episode 18: On the road with the LBCASponsor ContentFree webinar for radiology leaders